My Treatment Approach: Expert Insights Into the Management of Polycythemia Vera - Episode 12

Ruxolitinib in the Treatment of PV

,

Key opinion leaders discuss data on the use of ruxolitinib in patients with polycythemia vera.

EP. 1: Risk Assessment in Patients With Polycythemia Vera (PV)
EP. 2: Reducing Risk of Disease Progression in Patients With PV
EP. 3: Typical Presentation of a Patient With PV
EP. 4: Importance of Bone Marrow Biopsy For Diagnosis of PV
EP. 5: Reducing Risk of Thrombosis in Patients With PV
EP. 6: Factoring Symptom Burden Into Treatment Decision-Making for Patients With PV
EP. 7: Managing Toxicities of Hydroxyurea in Patients With PV
EP. 8: Managing Toxicities of Ropeginterferon Alpha-2b in Patients With PV
EP. 9: Key Trials in the Treatment of PV
EP. 10: Treatment Approaches for High-Risk Patients With PV
EP. 11: Influence of Driver Mutations on Response to Ropeginterferon Alpha-2b in Patients with PV
Now Viewing
EP. 12: Ruxolitinib in the Treatment of PV
EP. 13: Future Perspectives in the Treatment of Polycythemia Vera

Related Content:

My Treatment Approach: Expert Insights Into the Management of Polycythemia VeraMyeloproliferative NeoplasmsInsightsInsights Video Series
Single-Agent Immune Therapy in UC: The Need for More
Outlining the Current First-Line Treatment Landscape in Metastatic Urothelial Cancer: Starting With a Cisplatin-Ineligible Patient Case
Dr Grunwald on Monitoring Risk Factors for Disease Progression in PV